0001474064-12-000022.txt : 20120209
0001474064-12-000022.hdr.sgml : 20120209
20120209161051
ACCESSION NUMBER: 0001474064-12-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120207
FILED AS OF DATE: 20120209
DATE AS OF CHANGE: 20120209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANADILLO PEDRO P
CENTRAL INDEX KEY: 0001217544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 12587290
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2012-02-07
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001217544
GRANADILLO PEDRO P
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Common Stock
2012-02-07
4
A
0
15225
0
A
15225
D
Restricted Stock Units awarded under the 2005 Omnibus Incentive Plan that will be settled in NPS Common Stock as follows: one hundred percent will vest on the first anniversary of the date of grant.
/s/ Edward Stratemeier as Attorney-in-fact
2012-02-09